BRIAN STEIN: Open Payments
NPI 1275649212 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,735 in 74 payments from 17 companies in 2025. Trend: 2023 $1,517 · 2024 $1,720 · 2025 $1,735
Food & beverage: $1,735
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $401 |
| GlaxoSmithKline, LLC. | 10 | $197 |
| AstraZeneca Pharmaceuticals LP | 9 | $191 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $156 |
| Axsome Therapeutics, Inc. | 5 | $126 |
| Lilly USA, LLC | 5 | $102 |
| Exact Sciences Corporation | 5 | $98 |
| Amgen Inc. | 4 | $90 |
| Novo Nordisk Inc | 4 | $73 |
| Aimmune Therapeutics, Inc. | 3 | $70 |
Products named: VRAYLAR, TRELEGY ELLIPTA, CAPLYTA, Auvelity, AIRSUPRA, REXULTI, MOUNJARO, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
